Mode
Text Size
Log in / Sign up

Sarcopenia is associated with significantly higher risk of poor functional prognosis in stroke patientsSarcopenia Linked to Poorer Outcomes in Stroke Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that sarcopenia is associated with significantly higher risks of poor functional, motor, and cognitive outcomes.

This meta-analysis synthesized data from 36 cohort studies to evaluate the impact of sarcopenia on functional outcomes in stroke patients. The analysis found that sarcopenia is associated with a notably elevated risk of poor global functional prognosis (mRS) with an OR of 2.43 (95% CI: 1.95 to 3.03, p < 0.001). Additionally, patients with sarcopenia demonstrated significantly lower motor function scores (SMD = -0.94, 95% CI: -1.11 to -0.77, p < 0.001) and significantly lower cognitive function scores (SMD = -0.95, 95% CI: -1.22 to -0.69, p < 0.001).

The risk of swallowing dysfunction was also observed to be higher in the sarcopenia group (OR = 1.45, 95% CI: 0.94 to 2.25, p = 0.09), though this finding did not reach statistical significance. The authors noted several limitations, including heterogeneity in patient populations, stroke types, follow-up durations, and the specific diagnostic criteria used to define sarcopenia. Publication bias was also noted via Egger's test.

Clinically, these findings suggest that sarcopenia is a significant risk factor for poor global, motor, and cognitive outcomes following a stroke. The authors suggest that sarcopenia screening should be integrated into routine assessments for stroke patients to better identify those at risk for poor functional recovery.

How this fits prior evidence

This meta-analysis addresses a gap in identifying specific risk factors for poor functional outcomes in stroke patients. While previous evidence highlights the impact of heart failure on mortality and the efficacy of various rehabilitative therapies like rTMS and mirror therapy, this finding identifies sarcopenia as a specific indicator for poor global, motor, and cognitive outcomes. The association between sarcopenia and poor prognosis (OR 2.43) provides a specific metric for risk assessment in the post-stroke population.

A review of 36 different studies looked at the link between sarcopenia, which is the loss of muscle mass and strength, and recovery in people who have had a stroke. The researchers compared patients with sarcopenia to those without the condition to see how it affected their recovery.

The results showed that patients with sarcopenia had a much higher risk of poor overall functional outcomes. These patients also scored significantly lower on tests for motor skills and cognitive functions. While there was a slight increase in the risk of swallowing problems, this specific finding was not statistically significant in the data.

Because of these links, experts suggest that checking for muscle loss should be part of the routine care for stroke patients. However, it is important to note that this study was a meta-analysis of existing data, not a new clinical trial. There were also several differences in how the studies were conducted, such as different ways of measuring muscle loss and varying follow-up times. These factors mean the results show a link rather than a direct cause.

What this means for you:
Sarcopenia is linked to lower motor and cognitive scores in stroke patients, highlighting its role in recovery.

Common questions

What is sarcopenia and how does it affect stroke recovery?

Sarcopenia is the loss of muscle mass and strength. This study found that stroke patients with sarcopenia had a significantly higher risk of poor overall outcomes. They also showed lower scores in both motor functions and cognitive functions compared to patients without muscle loss.

Does sarcopenia increase the risk of swallowing problems after a stroke?

The study found a notable increase in the risk of swallowing dysfunction for patients with sarcopenia. However, this specific finding was not statistically significant, meaning the data did not provide a clear enough link to confirm it as a certain outcome.

How much of an impact does muscle loss have on motor and cognitive scores?

Patients with sarcopenia showed significantly lower scores in motor functions and cognitive functions. The study used standardized measures like the FIM-motor and Montreal Cognitive Assessment to confirm these lower scores in the sarcopenia group.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
OBJECTIVE: Sarcopenia has been demonstrated to correlate with the prognosis of stroke. This study aimed to systematically evaluate the impact of sarcopenia on global, motor, cognitive, and swallowing function outcomes in stroke patients. METHODS: Relevant studies investigating the association between sarcopenia and multidimensional prognostic outcomes in stroke were retrieved from the PubMed, Embase, Web of Science, Cochrane Library, and Scopus databases. The primary outcome was the risk of poor global functional prognosis assessed by the modified Rankin Scale (mRS). Secondary outcomes included motor function scores (Functional Independence Measure-motor, FIM-motor), cognitive function scores, and the risk of swallowing dysfunction. RESULTS: A total of 36 cohort studies were finally included. Pooled results indicated that stroke patients with comorbid sarcopenia faced a notably elevated risk of poor global functional prognosis (mRS, OR = 2.43, 95% CI: 1.95 to 3.03, p < 0.001). The motor function scores (FIM-motor, SMD = -0.94, 95% CI: -1.11 to -0.77, p < 0.001) and cognitive function scores (FIM-cognition or Montreal Cognitive Assessment, SMD = -0.95, 95% CI: -1.22 to -0.69, p < 0.001) in the sarcopenia group were significantly lower than those in the non-sarcopenia group, while the risk of swallowing dysfunction showed a notable but non-significant elevation (endotracheal intubation or Functional Oral Intake Scale, OR = 1.45, 95% CI: 0.94 to 2.25, p = 0.09). Subgroup analyses indicated that the patient populations, cut-off value of mRS, follow-up duration, stroke type, and diagnostic criteria for sarcopenia were the main sources of heterogeneity. Sensitivity analyses confirmed the robustness of the results. Egger's test suggested the presence of publication bias, but the conclusions remained valid after correction using the trim-and-fill method. CONCLUSION: Sarcopenia is an important risk factor for poor global, motor, cognitive, and swallowing function prognosis in stroke patients. In clinical practice, sarcopenia screening should be incorporated into the routine assessment of stroke patients, and individualized interventions should be promptly implemented for high-risk populations to improve long-term prognosis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.